Please login to the form below

Not currently logged in
Email:
Password:

Fresenius

This page shows the latest Fresenius news and features for those working in and with pharma, biotech and healthcare.

2022 PM Society Awards

2022 PM Society Awards

Other client Gold winners were Allergan Aesthetics, an AbbVie Company, Campaign Against Living Miserably (CALM), Fresenius Kabi, Greenwich BioSciences, Mölnlycke, Novo Nordisk, Roche/Chugai, Sanofi Genzyme and ViiV Healthcare.

Latest news

More from news
Approximately 7 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    business. The ancestors of these business model genera could already be seen in, for example, Roche, Mylan and Fresenius but in each case we have seen increasing specialisation and, consequently, differentiation.

  • Case study: What we're made of Case study: What we're made of

    Client:Fresenius Kabi. Agency:Page &Page. Campaign:What we're made of. Timescale:N/A. Malnutrition and dehydration cost the NHS over £19.6 billion annually. ... This empathetic approach has provided a halo effect for Fresenius Kabi’s reputation, as

  • KAM 2.0 KAM 2.0

    The Fresenius Helios hospital group, based in Germany, recently acquired the Spanish hospital group Grupo Hospitalario Quirónsalud to become the largest hospital group in Europe.

  • Pharma deals continue to slide Pharma deals continue to slide

    For example, Fresenius’s acquisition of NxStage Medical (US), a home dialysis competitor, for $2bn is being financed with cash and debt. ... Even so the Fresenius shareholders do not seem worried as the share price remained much the same after the

  • Deal Watch - May 2017 Deal Watch - May 2017

    Merck has spent 130m on the biosimilar programme which will be covered by the 170m upfront from Fresenius. ... 6, 100. Akorn (US). Fresenius (DE). Company acquisition. Manufacturing facilities and generic ophthalmic products with $1.1bn sales.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    He joins the pharma group from Fresenius Kabi, where he most recently led its US innovation and development centre. ... Prior to this, he served as chief scientific officer for Sabur Pharma, an oncology company that was acquired by Fresenius in 2008.

  • Galenica Group strengthens management team Galenica Group strengthens management team

    Currently chief executive of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), Schulze (pictured right) will take up his new roles in May 2017 reporting to Etienne Jornod, executive chairman of the ... development at Fresenius Medical Care for North

  • Zytoprotec expands supervisory board Zytoprotec expands supervisory board

    He served as vice president of biosciences at Fresenius Medical Care, a medical devices and services firm, as well as its global scientific ambassador between 1996 and 2013.

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma.

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....